View Clinical Trial (Medical Research Study)
Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System
| City: |
|
Houston |
| State: |
|
Texas |
| Zip Code: |
|
77030 |
| Conditions: |
|
Advanced Cancer |
| Purpose: |
|
The purpose of this study is to try to learn more about common symptoms that may occur in
patients due to cancer and its treatment. We also want to learn more about the impact of
symptoms on your quality of life. Another goal is to learn how to better measure symptoms
systematically when caring for patients.
|
| Study Summary: |
|
You will be asked to complete a form with some personal information. You will also be asked
to complete surveys that measure your mood and quality of life. You will be asked to
complete the symptom survey (the MD Anderson Symptom Inventory) that will ask you to rate
your symptoms and how much the symptoms interfere in your daily activities. Completing
these surveys takes about 20 minutes.
During your treatment, you may be asked to complete the symptom survey using the paper and
pencil method, or an electronic tablet, or you may be asked to complete it over the
telephone. If you are asked to use the phone method, we will use an interactive voice
response (IVR) telephone system to contact you to find out about symptoms you may be
experiencing. The research nurse will ask you for a convenient time for the system to call.
How often the system will call you during your treatment depends on the type of treatment
you are receiving. The research nurse will give you more information about the schedule of
calls to expect for the study and the times you will be asked to complete the mood and
quality of life surveys over the course of your treatment.
The information on your symptoms is being collected only for the research study. The
information will not be given to your doctors or nurses.
This is an investigational study. Up to 2,450 participants will participate in this study.
Up to 2,100 will be enrolled at MD Anderson.
|
| Criteria: |
|
Inclusion Criteria:
1) 1.) Normal Samples: Community dwelling adults > 18 years of age. 2.) Patient Samples:
In patients and out patients > 18 years of age, being followed at UT M.D. Anderson or a
collaborating site. Diagnosis of cancer confirmed by pathology.
Exclusion Criteria:
1) Those who refuse to participate or are determined incapable of completing the research.
|
| NCT ID: |
|
NCT00505245 |
| Primary Contact: |
|
Principal Investigator
Charles Cleeland, PhD
M.D. Anderson Cancer Center
Charles Cleeland, PhD
Phone: 713-745-3470
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Houston, Texas 77030
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|